Objective

This study examines clinical outcomes following the implementation of a computerized glucose management system (EndoTool) in two intensive care units that treat the majority of DKA admissions at Atrium Health Wake Forest Baptist Medical Center.

Setting

885-bed tertiary-care hospital in Winston-Salem, North Carolina.

Results

• Adoption of EndoTool IV was associated with an approximate 5-fold reduction in hypoglycemic BG values.
• Elimination of observed severe hypoglycemic BG values.
• Reduction in length of stay for DKA.

Conclusions

The authors concluded that EndoTool is effective in reducing hypoglycemic events in persons treated with intravenous insulin infusions (IVI) and may reduce DKA length of stay. Hospital systems considering a quality improvement project to reduce inpatient hypoglycemia for IVI should consider adoption of a computerized glucose management system such as EndoTool.